Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis

Clinical trial NCT00630994 · TERMINATED

Trial details

NCT number: NCT00630994
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Secondary Myelofibrosis

Start date: 2008-03-01
Primary completion: 2009-08-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.